Cargando…

Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients

BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in patients receiving hemodialysis. Systemic metabolic perturbation is one of the hallmark abnormalities in patients at high cardiovascular risk. We sought to determine the relationship between circulating ketone body...

Descripción completa

Detalles Bibliográficos
Autores principales: Obokata, Masaru, Negishi, Kazuaki, Sunaga, Hiroaki, Ishida, Hideki, Ito, Kyoko, Ogawa, Tetsuya, Iso, Tatsuya, Ando, Yoshitaka, Kurabayashi, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721877/
https://www.ncbi.nlm.nih.gov/pubmed/28974498
http://dx.doi.org/10.1161/JAHA.117.006885
_version_ 1783284903041826816
author Obokata, Masaru
Negishi, Kazuaki
Sunaga, Hiroaki
Ishida, Hideki
Ito, Kyoko
Ogawa, Tetsuya
Iso, Tatsuya
Ando, Yoshitaka
Kurabayashi, Masahiko
author_facet Obokata, Masaru
Negishi, Kazuaki
Sunaga, Hiroaki
Ishida, Hideki
Ito, Kyoko
Ogawa, Tetsuya
Iso, Tatsuya
Ando, Yoshitaka
Kurabayashi, Masahiko
author_sort Obokata, Masaru
collection PubMed
description BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in patients receiving hemodialysis. Systemic metabolic perturbation is one of the hallmark abnormalities in patients at high cardiovascular risk. We sought to determine the relationship between circulating ketone body and clinical outcomes in patients with prevalent hemodialysis. METHODS AND RESULTS: We retrospectively assessed the relationship between serum β‐hydroxybutyrate (βOHB), the most abundant ketone body in the circulation, and prognosis in 405 stable hemodialysis patients. During a mean follow‐up of 3.2±0.9 years, there were 54 major adverse cardiovascular events (defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization attributed to heart failure) and 67 all‐cause deaths. Major adverse cardiovascular events rates increased from 11.1 per 1000 person‐years in the lowest βOHB quintile (<89 μmol/L) to 80.1 per 1000 person‐years in the highest quintile (>409 μmol/L). After adjusting for demographic characteristics, coronary artery disease, and atrial fibrillation, the highest βOHB quintile was associated with increased risk of major adverse cardiovascular events compared with the lowest quintile (hazard ratio, 10.2; 95% confidence interval [3.35–44.0]; P<0.001). Increased quintiles of βOHB were independently and incrementally associated with major adverse cardiovascular events over the model based on an established risk score (the second Analyzing Data, Recognizing Excellence and Optimizing Outcomes cohort score) and N‐terminal pro‐B‐type natriuretic peptide (chi square 39.9 versus 21.7; P<0.001; c‐statistics, 0.713). Sensitivity analyses also confirmed the robustness of association between βOHB and all‐cause death. CONCLUSIONS: Increased serum βOHB levels were independently associated with cardiovascular events and all‐cause death in patients receiving hemodialysis. These results highlight the need for future studies to understand the mechanisms underlying these observations.
format Online
Article
Text
id pubmed-5721877
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57218772017-12-12 Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients Obokata, Masaru Negishi, Kazuaki Sunaga, Hiroaki Ishida, Hideki Ito, Kyoko Ogawa, Tetsuya Iso, Tatsuya Ando, Yoshitaka Kurabayashi, Masahiko J Am Heart Assoc Original Research BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in patients receiving hemodialysis. Systemic metabolic perturbation is one of the hallmark abnormalities in patients at high cardiovascular risk. We sought to determine the relationship between circulating ketone body and clinical outcomes in patients with prevalent hemodialysis. METHODS AND RESULTS: We retrospectively assessed the relationship between serum β‐hydroxybutyrate (βOHB), the most abundant ketone body in the circulation, and prognosis in 405 stable hemodialysis patients. During a mean follow‐up of 3.2±0.9 years, there were 54 major adverse cardiovascular events (defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization attributed to heart failure) and 67 all‐cause deaths. Major adverse cardiovascular events rates increased from 11.1 per 1000 person‐years in the lowest βOHB quintile (<89 μmol/L) to 80.1 per 1000 person‐years in the highest quintile (>409 μmol/L). After adjusting for demographic characteristics, coronary artery disease, and atrial fibrillation, the highest βOHB quintile was associated with increased risk of major adverse cardiovascular events compared with the lowest quintile (hazard ratio, 10.2; 95% confidence interval [3.35–44.0]; P<0.001). Increased quintiles of βOHB were independently and incrementally associated with major adverse cardiovascular events over the model based on an established risk score (the second Analyzing Data, Recognizing Excellence and Optimizing Outcomes cohort score) and N‐terminal pro‐B‐type natriuretic peptide (chi square 39.9 versus 21.7; P<0.001; c‐statistics, 0.713). Sensitivity analyses also confirmed the robustness of association between βOHB and all‐cause death. CONCLUSIONS: Increased serum βOHB levels were independently associated with cardiovascular events and all‐cause death in patients receiving hemodialysis. These results highlight the need for future studies to understand the mechanisms underlying these observations. John Wiley and Sons Inc. 2017-10-03 /pmc/articles/PMC5721877/ /pubmed/28974498 http://dx.doi.org/10.1161/JAHA.117.006885 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Obokata, Masaru
Negishi, Kazuaki
Sunaga, Hiroaki
Ishida, Hideki
Ito, Kyoko
Ogawa, Tetsuya
Iso, Tatsuya
Ando, Yoshitaka
Kurabayashi, Masahiko
Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title_full Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title_fullStr Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title_full_unstemmed Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title_short Association Between Circulating Ketone Bodies and Worse Outcomes in Hemodialysis Patients
title_sort association between circulating ketone bodies and worse outcomes in hemodialysis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721877/
https://www.ncbi.nlm.nih.gov/pubmed/28974498
http://dx.doi.org/10.1161/JAHA.117.006885
work_keys_str_mv AT obokatamasaru associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT negishikazuaki associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT sunagahiroaki associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT ishidahideki associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT itokyoko associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT ogawatetsuya associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT isotatsuya associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT andoyoshitaka associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients
AT kurabayashimasahiko associationbetweencirculatingketonebodiesandworseoutcomesinhemodialysispatients